Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer

BACKGROUNDS: Overexpression of epidermal growth factor receptor (EGFR) has been established as a valid therapeutic target of non-small cell lung cancer (NSCLC). However, the clinical benefit of cetuximab as an EGFR-targeting drug is still controversial, partially due to the lack of effective means t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Aiko, Achmad, Arifudin, Hanaoka, Hirofumi, Heryanto, Yusri Dwi, Bhattarai, Anu, Ratianto, Khongorzul, Erdene, Shintawati, Rini, Kartamihardja, A. Adhipatria P., Kanai, Ayaka, Sugo, Yumi, S. Ishioka, Noriko, Higuchi, Tetsuya, Tsushima, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813975/
https://www.ncbi.nlm.nih.gov/pubmed/31651282
http://dx.doi.org/10.1186/s12885-019-6238-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813975/
https://www.ncbi.nlm.nih.gov/pubmed/31651282
http://dx.doi.org/10.1186/s12885-019-6238-4

Ejemplares similares